Written by Seyyed Mohammad Mousavi ; Javad Golmirzaei ; Yaghoub Hamedi ; Forough Mahmoudi ; Hamidreza Mahboobi ; Mohammad Esmaeil Shahrzad ; Fatemeh Hafezipour ; Maryam Tashk ; Samaneh Bavaghari
Parent Category: Browse issues of Electronic Physician by year and volume
Category: Year 2011, Volume 3
Objective: Schizophrenia is a harmful disorder with an unknown etiology that causes dysfunction and interferes with work, school and the patient's communications. The prevalence and incidence rate of schizophrenia varies in different countries. The aim of the current study is to investigate the epidemiology of schizophrenia in Bandarabbass in 2009.
Methods: This descriptive and retrospective study was conducted in 2009 in Ebnesina Mental Hospital and patients who were diagnosed with schizophrenia according to the DSM-IV criteria were enrolled (198 patients). Then, by using a checklist prepared by a psychiatry specialist, the data was extracted from the medical records. The gathered data was analyzed by SPSS 19 using the descriptive statistics test.
Results: The mean age of the 198 participants was 36.5±11.591, and 69.2 percent of them were male and 30.8 percent were female. Also 60.6 percent of the patients were married and 76.8 percent were unemployed. Four percent had diabetes and 3 percent were hypertensive and 84.3 percent didn't have substance use comorbidity. Hallucinations were seen in 45.4 percent of the patients and 60.1 percent experienced delusions.
Conclusion: As discussed above, many of the symptoms were different in Bandarabbass and this confirms that race plays a significant role in schizophrenia and its symptoms. Therefore more research must be performed about schizophrenia in different regions. Since the presentation of this disorder varies, unique treatments according to patient’s race might be needed.
Key words: schizophrenia, epidemiology, symptoms
Puma Rihanna CreeperNike
The most recent editorial (June 2021)
Ethics of Publishing Case Reports: Do We Need Ethics Approval and Patient Consent?
An editorial by Dr. Mehrdad Jalalian
The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.
To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here
Our previous editorial (June 2020)
Lessons from COVID-19 pandemic and the Morocco’s success story.
An editorial by Dr. Benksim Abdelhafid (Morocco)
The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.
The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:
TDR Clinical Research and Development Fellowships
Call for applications
Deadline for submission: 7 March 2019, 16:00 (GMT)
TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:
Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019
Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).
About the Instructor
Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more: